Skip to content
Tech News
← Back to articles

Elizabeth Holmes Is Reportedly Plotting a New Theranos From Behind Bars

read original get Bad Blood" by John Carreyrou → more articles
Why This Matters

Elizabeth Holmes, mid-way through an 11-year fraud sentence, is reportedly working with her partner Billy Evans on a 'Theranos 2.0,' per a new documentary by Nathan Fielder and Lance Oppenheim. It's a reminder of how little accountability tends to stick to Silicon Valley founders, and how easily hype can be resurrected even after a landmark fraud conviction. For investors and consumers, it raises fresh questions about diligence in health-tech, a sector where false claims carry real medical risk.

Key Takeaways
Worth a Look

Bad Blood" by John Carreyrou — Carreyrou's bestselling investigation is the definitive account of how Theranos raised hundreds of millions before its blood-testing claims collapsed. If the new documentary has you fascinated by Elizabeth Holmes, this is the essential backstory in one gripping read.

See Bad Blood" by John Carreyrou on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.

Listen to this post

Elizabeth Holmes is serving an 11-year sentence for defrauding investors out of hundreds of millions of dollars. According to a new documentary, that hasn’t stopped her from planning her next act.

“You Can See Everything,” from comedian Nathan Fielder and director Lance Oppenheim, premiered in a secret screening at the Telluride Film Festival, capturing Holmes and her partner, Billy Evans, over three years, starting 34 days before she reported to prison. In several scenes, the film shows Holmes and Evans on calls with prospective partners about launching what’s described as a “Theranos 2.0,” a business Evans says he plans to build while Holmes serves her sentence, according to NBC News.

Watch the trailer below, which is generating tremendous amount of buzz based on the sheer weirdness of it.

In its heyday, Theranos raised more than $900 million from investors including Rupert Murdoch and the Walton family. Then its blood-testing technology was revealed to be a fraud. Holmes was once worth an estimated $4.5 billion. Forbes revised that number to zero in 2016.